Ironwood Pharmaceuticals Overview

  • Founded
  • 1998

Founded
  • Status
  • Public

  • Employees
  • 219

Employees
  • Stock Symbol
  • IRWD

Stock Symbol
  • Share Price
  • $12.01

  • (As of Tuesday Closing)

Ironwood Pharmaceuticals General Information

Description

Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Drug Discovery
Stock Exchange
NAS
Primary Office
  • 100 Summer Street
  • Suite 2300
  • Boston, MA 02110
  • United States
+1 (617) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ironwood Pharmaceuticals Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$12.01 $11.91 $10.13 - $14.21 $1.82B 153M 3.43M $1.08

Ironwood Pharmaceuticals Financials Summary

In Thousands,
USD
TTM 30-Jun-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 1,717,142 1,804,020 1,964,369 2,383,287
Revenue 415,637 413,753 389,523 428,413
EBITDA 236,101 232,604 140,399 98,263
Net Income 173,100 528,448 106,176 21,505
Total Assets 975,690 1,126,927 559,238 402,748
Total Debt 416,084 475,802 453,702 431,222
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Ironwood Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Ironwood Pharmaceuticals‘s full profile, request access.

Request a free trial

Ironwood Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Ironwood Pharmaceuticals‘s full profile, request access.

Request a free trial

Ironwood Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segmen
Pharmaceuticals
Boston, MA
219 As of 2021
00000
000000000 00000

000000

s nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit
0000000000000
San Francisco, CA
00 As of 0000
000.00
000 0000-00-00
00000000000 000.00

000000

t, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis
0000 000000000
Cambridge, MA
0000 As of 0000
00.000
0000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Ironwood Pharmaceuticals Competitors (31)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
OrphoMed Venture Capital-Backed San Francisco, CA 00 000.00 00000000000 000.00
0000000 0000000000 Formerly VC-backed Cambridge, MA 0000 00.000 0000 00.000
0000000 000000000 Formerly VC-backed Tel Aviv, Israel 000 00000 000000000 00000
000000000 00000000 Private Equity-Backed San Diego, CA 000 00000 0000000 0000 00000
0000000000 0000000 Formerly VC-backed San Diego, CA 000 00000 000000&0
You’re viewing 5 of 31 competitors. Get the full list »

Ironwood Pharmaceuticals Patents

Ironwood Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210261690-A9 Method of generating anti-linaclotide antibodies and uses thereof Abandoned 11-May-2018 000000000
AU-2018302255-A1 Efficacy of a gastro-retentive bile acid sequestrant dosage form Pending 19-Jul-2017 0000000000
US-20200138854-A1 Method of detecting and quantifying bile acid from saliva Abandoned 19-Jul-2017 0000000000
CA-3070082-A1 Efficacy of a gastro-retentive bile acid sequestrant dosage form Pending 19-Jul-2017 0000000000
EP-3654953-A4 Efficacy of a gastro-retentive bile acid sequestrant dosage form Pending 19-Jul-2017 A61K31/785
To view Ironwood Pharmaceuticals’s complete patent history, request access »

Ironwood Pharmaceuticals Executive Team (30)

Name Title Board Seat Contact Info
Thomas McCourt Chief Executive Officer & Board Member
Sravan Emany Chief Financial Officer, Finance & Senior Vice President
Jason Rickard Chief Operating Officer, Operations & Senior Vice President
Ronald Silver Chief Accounting Officer, Accounting & Controller, Finance
Christina Kaldany Director of Business Development
You’re viewing 5 of 30 executive team members. Get the full list »

Ironwood Pharmaceuticals Board Members (23)

Name Representing Role Since
Alexander Denner Ph.D Self Board Member 000 0000
Andrew Dreyfus Self Board Member 000 0000
Benjamin Cravatt Ph.D Self Board Member, Advisory Team 000 0000
Catherine Moukheibir Self Board Member 000 0000
Edward Owens Self Board Member 000 0000
You’re viewing 5 of 23 board members. Get the full list »

Ironwood Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ironwood Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Ironwood Pharmaceuticals‘s full profile, request access.

Request a free trial